Related Experiment Video
Updated: Nov 19, 2025

Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
Published on: January 12, 2024
Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?
Laura Kate Gadanec1, Kristen Renee McSweeney1, Tawar Qaradakhi1
1Institute for Health and Sport, Victoria University, 3030 Melbourne, Australia.
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) uses spike proteins to infect cells, potentially through receptors beyond ACE2. Targeting these alternative receptors may offer new COVID-19 therapies.
Area of Science:
- Virology
- Immunology
- Cell Biology
Background:
- Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes COVID-19, a global health threat.
- The SARS-CoV-2 spike (S) protein typically uses ACE2 for host cell entry.
- Viral entry into ACE2-negative cells suggests alternative receptor usage.
Purpose of the Study:
- Investigate alternative SARS-CoV-2 S protein interactions beyond ACE2.
- Identify novel host cell receptors involved in viral entry and pathogenesis.
- Explore potential therapeutic targets for COVID-19.
Main Methods:
- Review of existing studies on SARS-CoV-2 S protein interactions.
- Analysis of reported viral tropism in cells lacking ACE2.
- Examination of S protein interactions with innate immune receptors and non-immune receptors.
Main Results:
- SARS-CoV-2 S protein interacts with C-lectin type receptors (CLR), toll-like receptors (TLR), neuropilin-1 (NRP1), and glucose regulated protein 78 (GRP78).
- Carbohydrate recognition on the S protein may mediate receptor-dependent entry and inflammation.
- These alternative pathways may facilitate systemic infection independently of ACE2.
Conclusions:
- SARS-CoV-2 utilizes multiple host cell receptors for entry, not solely ACE2.
- Targeting receptors like TLRs and CLRs could enhance antiviral immunity and viral clearance.
- These findings suggest new therapeutic strategies against COVID-19 by targeting alternative receptors.
More Related Videos
08:40Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Related Concept Videos
Receptor-mediated Endocytosis
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Viral Recombination
Viruses with RNA Genomes
Retrovirus Life Cycles